Journal List > Korean J Gastroenterol > v.64(1) > 1007280

Lee, Kim, Chae, Han, Lee, Jang, Yoo, Jung, Park, Kim, Cho, Sohn, Jeon, Kim, and Park: Correlation between Adenoma Detection Rate and Advanced Adenoma Detection Rate

Abstract

Background/Aims

Adenoma detection rate (ADR) is widely used as an index of colonoscopy quality management. Although advanced adenomas can be found less frequently than non-advanced adenomas, advanced adenomas have a higher clinical significance during screening for colorectal cancer. The aim of this study was to investigate the correlation between advanced and non-advanced ADR among colonoscopists.

Methods

This study is an observational study of a cohort of patients undergoing screening colonoscopy between 2009 and 2010. We collected the data on patients' characteristics and colonoscopic findings. The detection rates of adenoma and advanced adenoma were calculated. Logistic regression was used to determine the effects of variables on advanced adenoma detection, and spearman's rank-order correlation was used to evaluate the relationship between advanced ADR and ADR. Results: A total of 561 patients underwent screening colonoscopy by 18 experienced colonoscopists. Most colonoscopists had adequate (>20%) ADRs. Logistic regression showed that increased patient age (OR 1.07 per 1 year increase, 95% CI 1.009–1.133, p=0.023) and male gender (OR 1.860, 95% CI 0.764–4.529, p=0.171) were associated with advanced ADR. When colonoscopists were divided into two groups on the basis of advanced ADR of 5%, ADR was also significantly higher in the group having higher level of advanced ADR. However, there was no correlation between advanced ADR and ADR among colonoscopists as an individual.

Conclusions

Colonoscopists' advanced ADRs were independent of their ADRs, indicating that advanced ADR could be quite low even among colonoscopists with acceptable ADRs. Thus, there seems to be a limitation in using ADR as an adequate index of colonoscopy quality management.

References

1. Ministry of Health & Welfare, National Cancer Center. Cancer facts & figures 2014. Seoul: Ministry of Health & Welfare; Goyang: National Cancer Center;2014.
2. Lee SH, Park DI, Sung JM, et al. Usefulness of polyp detection rate as a quality indicator in colonoscopy. Intest Res. 2011; 9:105–111.
crossref
3. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112:24–28.
crossref
4. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004; 141:352–359.
crossref
5. Greenspan M, Rajan KB, Baig A, Beck T, Mobarhan S, Melson J. Advanced adenoma detection rate is independent of non-advanced adenoma detection rate. Am J Gastroenterol. 2013; 108:1286–1292.
crossref
6. Moon CM. Quality indicators of colonoscopy: old and news. Korean Soc Gastrointest Endosc. 2013; 49:134–136.
7. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010; 362:1795–1803.
crossref
8. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011; 306:1352–1358.
crossref
9. Choe JW, Chang HS, Yang SK, et al. Screening colonoscopy in asymptomatic average-risk Koreans: analysis in relation to age and sex. J Gastroenterol Hepatol. 2007; 22:1003–1008.
crossref
10. Park HW, Byeon JS, Yang SK, et al. Colorectal neoplasm in asymptomatic average-risk Koreans: the KASID prospective multicenter colonoscopy survey. Gut Liver. 2009; 3:35–40.
crossref
11. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006; 355:1863–1872.
crossref
12. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006; 355:2533–2541.
crossref
13. Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D, Schmiegel W. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology. 2012; 142:1460–1467.e2.
crossref
14. Nagorn A, Katic V, Zivkovic V, Stanojevic G. Advanced colorectal adenoma. Arch Oncol. 2004; 12(Suppl 1):59–60.
15. Imperiale T, Glowinski EA, Lin-Cooper C, Ransohoff DF. Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med. 2012; 125:1181–1187.
crossref
16. Benson ME, Reichelderfer M, Said A, Gaumnitz EA, Pfau PR. Variation in colonoscopic technique and adenoma detection rates at an academic gastroenterology unit. Dig Dis Sci. 2010; 55:166–171.
crossref
17. Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Intest Res. 2012; 10:67–88.
crossref

Fig. 1.
Study enrollment. a Performed <10 colonoscopies during the study period.
kjg-64-18f1.tif
Fig. 2.
Adenoma detection rate (ADR) vs. advanced ADR for all colonoscopists.
kjg-64-18f2.tif
Table 1.
Demographic Characteristics of the Participants Who Underwent Screening Colonoscopy
Age group (yr) Male Female Total
41–50 62 35 97 (17.3)
51–60 198 135 333 (59.3)
61–70 64 49 113 (20.1)
>71 5 13 18 (3.2)
Total 329 (58.6) 232 (41.4) 561

Values are presented as n only or n (%).

Table 2.
Adenoma and Advanced Adenoma Detection Rates of the Individual Colonoscopist
Colonoscopist Patients (n) Patients with adenomas (n) Patients with advanced adenoma (n) ADR (%) Advanced ADR (%)
A 23 11 2 47.83 8.7
B 34 13 3 38.24 8.82
C 51 26 3 50.98 5.88
D 52 21 2 40.38 3.85
E 23 7 0 30.43 0
F 57 20 1 35.08 1.75
G 13 4 0 30.77 0
H 56 28 3 50 5.36
I 16 6 2 37.5 12.5
J 21 10 3 47.62 14.29
K 45 17 1 37.77 2.22
L 46 18 2 39.13 4.35
M 22 5 1 22.73 4.55
N 27 11 1 40.74 3.7
O 26 8 1 30.76 3.85
P 18 5 0 27.77 0
Q 19 3 0 15.79 0
R 12 6 0 50 0
Total 561 218 25 38.86 4.46

ADR, adenoma detection rate.

Table 3.
Comparison of Adenoma Detection Rates of Colonoscopists on the Basis of Advanced Adenoma Detection Rate
Advanced ADR Mean ADR (%) p-value a OR (95% CI)
≤3% 41.98 0.078 1.377 (0.964–1.966)
>3% 33.16    
≤4% 43.49 0.064 1.381 (0.981–1.944)
>4% 34.93    
≤5% 46.77 0.009 1.613 (1.125–2.313)
>5% 34.72    
≤6% 42.55 0.674 1.113 (0.675–1.837)
>6% 38.33    
≤10% 43.24 0.91 0.942 (0.338–2.631)
>10% 38.74    

a Obtained using the 2 test for categorical variables.

ADR, adenoma detection rate.

Table 4.
Logistic Regression Analysis of Advanced Adenomas with Increasing Patient Age, Male Gender, and Withdrawal Time
  Patients, n (%) p-value a OR (95% CI)
Age group (yr)      
41–50 97 (17.3) 1
51–60 333 (59.3) 0.1 5.486 (0.723–41.62)
61–70 113 (20.1) 0.408 2.618 (0.268–25.59)
>71 18 (3.2) 0.013 19.2 (1.87–196.8)
Withdrawal time (min) Sex   <0.001 1.191 (1.094–1.296)
Female 232 (41.4)   1
Male 329 (58.6) 0.171 1.860 (0.764–4.529)

a Obtained using the 2 test for categorical variables.

TOOLS
Similar articles